Women with a family history of breast cancer could be offered preventative medication on the NHS under new plans outlined by the health regulator.
Officials are examining whether women who are at "high risk" of developing the disease should be offered hormone therapy to prevent breast cancer.
The National Institute of Health and Clinical Excellence (Nice) has launched a draft consultation to see whether drugs tamoxifen or raloxifene should be offered to high-risk post-menopausal women in England and Wales.
More top news
A summary of the key announcements from Chancellor George Osborne's Autumn Statement and Spending Review.
All cuts have consequences, warns Joel Hills, as he examines which assets may be up for sale if George Osborne decides 'everything must go'.
Tests revealed she was suffering from secretory carcinoma - which affects just "one in a million people" diagnosed with the breast cancer.